Literature DB >> 27509238

Challenges in Recruiting People Who Use Drugs for HIV-Related Biomedical Research: Perspectives from the Field.

Pedro Batista1, Sherry Deren1, Angela Banfield2, Evelyn Silva1, Mario Cruz3, Preston Garnes4, Charles M Cleland1, Saurabh Mehandru5, Melissa LaMar6, Martin Markowitz6.   

Abstract

Recruitment of people who use drugs (PWUD) for HIV-related research has been undertaken since early in the epidemic. In early studies, recruitment was often performed by outreach workers with familiarity with the target population, who distributed risk reduction materials, and administered the surveys being conducted on drug use and risk behaviors. The evolution of effective treatments for HIV has provided opportunities for PWUD to participate in biobehavioral studies testing the efficacy of medical treatment advances and exploring the underlying biomedical basis for prevention and treatment efforts. Recruitment for these studies has led to new challenges for outreach workers and institutions conducting this research. PWUD, particularly those from race/ethnic minority populations, have had lower rates of engagement in HIV care and have been underrepresented in HIV/AIDS medical studies. To address these health disparities, enhanced efforts are needed to increase their participation in biomedical studies. This article examines the challenges identified by experienced outreach workers in recruiting PWUD for HIV-related biomedical studies, including individual (participant)-, institutional-, and recruiter-level challenges, and provides recommendations for addressing them.

Entities:  

Mesh:

Year:  2016        PMID: 27509238      PMCID: PMC4991596          DOI: 10.1089/apc.2016.0135

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  8 in total

1.  AIDS outreach workers: an exploratory study of job satisfactions/dissatisfactions.

Authors:  S Deren; W R Davis; S Tortu; S Friedman; S Tross; M Sufian; J Pascal; C Stull
Journal:  AIDS Educ Prev       Date:  1992

2.  The promise of outreach for engaging and retaining out-of-care persons in HIV medical care.

Authors:  Judith B Bradford
Journal:  AIDS Patient Care STDS       Date:  2007       Impact factor: 5.078

3.  ACT2 peer-driven intervention increases enrollment into HIV/AIDS medical studies among African Americans/Blacks and Hispanics: A cluster randomized controlled trial.

Authors:  Marya Gwadz; Charles M Cleland; Mindy Belkin; Amanda Ritchie; Noelle Leonard; Marion Riedel; Angela Banfield; Pablo Colon; Vanessa Elharrar; Jonathan Kagan; Donna Mildvan
Journal:  AIDS Behav       Date:  2014-12

4.  Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials.

Authors:  Marya Viorst Gwadz; Pablo Colon; Amanda S Ritchie; Noelle R Leonard; Charles M Cleland; Marion Riedel; DeShannon Bowens; Angela D Banfield; Patricia Chang; Robert Quiles; Donna Mildvan
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

Review 5.  Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities.

Authors:  Jaimie P Meyer; Amy L Althoff; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2013-06-23       Impact factor: 9.079

Review 6.  Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention.

Authors:  Shayesta Dhalla; Gary Poole
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 7.  Outreach-based HIV prevention for injecting drug users: a review of published outcome data.

Authors:  S L Coyle; R H Needle; J Normand
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

8.  Description of an efficacious behavioral peer-driven intervention to reduce racial/ethnic disparities in AIDS clinical trials.

Authors:  N R Leonard; A Banfield; M Riedel; A S Ritchie; D Mildvan; G Arredondo; C M Cleland; M V Gwadz
Journal:  Health Educ Res       Date:  2013-05-13
  8 in total
  5 in total

1.  Brief Report: The Relationship Between Injection Drug Use Risk Behaviors and Markers of Immune Activation.

Authors:  Sherry Deren; Charles M Cleland; Haekyung Lee; Saurabh Mehandru; Martin Markowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

2.  Peer-based Retention Of people who Use Drugs in Rural Research (PROUD-R2): a multisite, randomised, 12-month trial to compare efficacy of standard versus peer-based approaches to retain rural people who use drugs in research.

Authors:  April M Young; Kathryn E Lancaster; Sarann Bielavitz; Miriam R Elman; Ryan R Cook; Gillian Leichtling; Edward Freeman; Angela T Estadt; Morgan Brown; Rhonda Alexander; Caiti Barrie; Kandi Conn; Rhody Elzaghal; Lisa Maybrier; Renee McDowell; Cathy Neal; Jodi Lapidus; Elizabeth N Waddell; P Todd Korthuis
Journal:  BMJ Open       Date:  2022-06-15       Impact factor: 3.006

3.  Recruitment into a Clinical Trial of People Living with Uncontrolled HIV Infection Who Inject Drugs: a Site Case Report from the CTN 67 CHOICES Study.

Authors:  Hansel Tookes; Jessica Ucha; Allan E Rodriguez; Edward Suarez; Elizabeth Alonso; Lisa R Metsch; Daniel J Feaster; Tyler S Bartholomew; Kim A Hoffman; P Todd Korthuis
Journal:  J Behav Health Serv Res       Date:  2021-09-29       Impact factor: 1.475

4.  Willingness to Participate in Hypothetical HIV Vaccine Trial and Associated Factors among People Who Inject Drugs in Dar es Salaam, Tanzania.

Authors:  Masunga K Iseselo; Edith A M Tarimo; Eric Sandstrom; Asli Kulane
Journal:  Biomed Res Int       Date:  2020-07-02       Impact factor: 3.411

5.  A cross-sectional survey of potential factors, motivations, and barriers influencing research participation and retention among people who use drugs in the rural USA.

Authors:  Angela T Hetrick; April M Young; Miriam R Elman; Sarann Bielavitz; Rhonda L Alexander; Morgan Brown; Elizabeth Needham Waddell; P Todd Korthuis; Kathryn E Lancaster
Journal:  Trials       Date:  2021-12-20       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.